Jun Naniwa

479 total citations
19 papers, 399 citations indexed

About

Jun Naniwa is a scholar working on Molecular Biology, Reproductive Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Jun Naniwa has authored 19 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Reproductive Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Jun Naniwa's work include Ovarian cancer diagnosis and treatment (8 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Cancer Mechanisms and Therapy (5 papers). Jun Naniwa is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Cancer Mechanisms and Therapy (5 papers). Jun Naniwa collaborates with scholars based in Japan. Jun Naniwa's co-authors include Hiroaki Itamochi, Junzo Kigawa, Tetsuro Oishi, Muneaki Shimada, Naoki Terakawa, Shinya Sato, Seiya Sato, Michiko Nonaka, Yasunobu Kanamori and Tasuku Harada and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Cell and Tissue Research.

In The Last Decade

Jun Naniwa

18 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Naniwa Japan 13 223 158 114 79 75 19 399
Zhifei Zu United States 7 235 1.1× 255 1.6× 110 1.0× 87 1.1× 63 0.8× 8 461
Terry Hurst Australia 11 276 1.2× 202 1.3× 157 1.4× 76 1.0× 35 0.5× 18 477
Diana P. English United States 14 140 0.6× 98 0.6× 232 2.0× 55 0.7× 114 1.5× 24 447
Jin Yun Chen United States 5 218 1.0× 275 1.7× 124 1.1× 32 0.4× 84 1.1× 7 512
Monica Dandapani United States 7 200 0.9× 83 0.5× 97 0.9× 96 1.2× 29 0.4× 14 396
G. Spatti Italy 6 126 0.6× 100 0.6× 219 1.9× 64 0.8× 28 0.4× 7 358
Huiyu Zhuang China 13 237 1.1× 146 0.9× 75 0.7× 28 0.4× 58 0.8× 21 436
Lina Albitar United States 10 204 0.9× 51 0.3× 117 1.0× 37 0.5× 69 0.9× 12 374
J. Schwarz Germany 7 165 0.7× 50 0.3× 61 0.5× 29 0.4× 30 0.4× 9 308
Yu-Ping Liao Taiwan 10 363 1.6× 74 0.5× 154 1.4× 29 0.4× 49 0.7× 10 508

Countries citing papers authored by Jun Naniwa

Since Specialization
Citations

This map shows the geographic impact of Jun Naniwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Naniwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Naniwa more than expected).

Fields of papers citing papers by Jun Naniwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Naniwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Naniwa. The network helps show where Jun Naniwa may publish in the future.

Co-authorship network of co-authors of Jun Naniwa

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Naniwa. A scholar is included among the top collaborators of Jun Naniwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Naniwa. Jun Naniwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Oishi, Tetsuro, Hiroaki Itamochi, Seiya Sato, et al.. (2014). Dual Inhibition of Phosphatidylinositol 3’-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach for Mucinous Adenocarcinoma of the Ovary. International Journal of Gynecological Cancer. 24(3). 444–453. 16 indexed citations
2.
Oishi, Tetsuro, Hiroaki Itamochi, Michiko Nonaka, et al.. (2014). The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma. Oncology Reports. 32(2). 553–558. 35 indexed citations
3.
Naniwa, Jun, Hiroaki Itamochi, Yasushi Horie, et al.. (2014). Recurrent spontaneous pneumothorax following chemotherapy in a patient with ovarian granulosa cell tumor. International Cancer Conference Journal. 4(1). 18–21.
4.
Shimada, Muneaki, Seiya Sato, Imari Deura, et al.. (2013). Outcome of stage IB2–IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy. International Journal of Clinical Oncology. 19(2). 348–353. 14 indexed citations
5.
Itamochi, Hiroaki, Mayumi Nishimura, Tetsuro Oishi, et al.. (2013). Checkpoint Kinase Inhibitor AZD7762 Overcomes Cisplatin Resistance in Clear Cell Carcinoma of the Ovary. International Journal of Gynecological Cancer. 24(1). 61–69. 38 indexed citations
6.
Itamochi, Hiroaki, Mayumi Nishimura, Tetsuro Oishi, et al.. (2013). Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene. Human Cell. 26(3). 121–127. 12 indexed citations
7.
Oishi, Tetsuro, Hiroaki Itamochi, Michiko Nonaka, et al.. (2013). Abstract 3256: A novel therapy for mucinous adenocarcinoma of the ovary by using NVP-BEZ235 to inhibit PI3K and mTOR.. Cancer Research. 73(8_Supplement). 3256–3256. 1 indexed citations
8.
Itamochi, Hiroaki, Mayumi Nishimura, Tetsuro Oishi, et al.. (2012). Establishment and characterization of a novel ovarian serous adenocarcinoma cell line, TU-OS-4, that overexpresses EGFR and HER2. Human Cell. 25(4). 111–115. 5 indexed citations
9.
Nonaka, Michiko, Hiroaki Itamochi, Seiya Sato, et al.. (2012). Activation of the Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Pathway Overcomes Cisplatin Resistance in Ovarian Carcinoma Cells. International Journal of Gynecological Cancer. 22(6). 922–929. 12 indexed citations
10.
Itamochi, Hiroaki, Michiko Nonaka, Seiya Sato, et al.. (2011). Abstract 2561: Inhibiting the mTOR pathway synergistically enhances etoposide-induced cytotoxicity by upregulating c-Jun in ovarian cancer cells. Cancer Research. 71(8_Supplement). 2561–2561. 3 indexed citations
11.
Itamochi, Hiroaki, Tetsuro Oishi, Muneaki Shimada, et al.. (2011). Inhibiting the mTOR Pathway Synergistically Enhances Cytotoxicity in Ovarian Cancer Cells Induced by Etoposide through Upregulation of c-Jun. Clinical Cancer Research. 17(14). 4742–4750. 24 indexed citations
12.
Sato, Shinya, Hiroaki Itamochi, Muneaki Shimada, et al.. (2009). Preoperative and Intraoperative Assessments of Depth of Myometrial Invasion in Endometrial Cancer. International Journal of Gynecological Cancer. 19(5). 884–887. 23 indexed citations
13.
Sato, Seiya, Hiroaki Itamochi, Junzo Kigawa, et al.. (2008). Combination chemotherapy of oxaliplatin and 5‐fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: A potential treatment strategy. Cancer Science. 100(3). 546–551. 61 indexed citations
14.
Naniwa, Jun, Junzo Kigawa, Yasunobu Kanamori, et al.. (2006). Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer. International Journal of Gynecological Cancer. 17(1). 76–82. 30 indexed citations
15.
Kanamori, Yasunobu, Junzo Kigawa, Jun Naniwa, et al.. (2005). PTEN is involved in the signal transduction pathway of contact inhibition in endometrial cells. Cell and Tissue Research. 323(3). 523–528. 12 indexed citations
16.
Kanamori, Yasunobu, Junzo Kigawa, Jun Naniwa, et al.. (2005). PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma. Oncology Reports. 14(2). 389–92. 52 indexed citations
17.
Kigawa, Junzo, Yasunobu Kanamori, Hiroaki Itamochi, et al.. (2004). Expression of the c‐myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer. Cancer Science. 95(5). 418–423. 41 indexed citations
18.
Sato, Shinya, Junzo Kigawa, Yasunobu Kanamori, et al.. (2004). Activity of docetaxel in paclitaxel-resistant ovarian cancer cells. Cancer Chemotherapy and Pharmacology. 53(3). 247–252. 9 indexed citations
19.
Naniwa, Jun, Junzo Kigawa, Yasunobu Kanamori, et al.. (2003). Leptomycin B enhances CDDP‐sensitivity via nuclear accumulation of p53 protein in HPV‐positive cells. Cancer Science. 94(12). 1099–1103. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhifei Zu Breakdown of academic impact, for papers by Terry Hurst Breakdown of academic impact, for papers by Diana P. English Breakdown of academic impact, for papers by Jin Yun Chen Breakdown of academic impact, for papers by Monica Dandapani Breakdown of academic impact, for papers by G. Spatti Breakdown of academic impact, for papers by Huiyu Zhuang Breakdown of academic impact, for papers by Lina Albitar Breakdown of academic impact, for papers by J. Schwarz Breakdown of academic impact, for papers by Yu-Ping Liao
Rankless by CCL
2026